| 启明医疗-B |
曾敏 |
增持 |
38651618 |
3865.16万股 |
0.09% |
好仓 |
2020-11-27 |
| 启明医疗-B |
曾敏 |
减持 |
-38651618 |
930.28万股 |
1.00% |
好仓 |
2020-11-27 |
| 启明医疗-B |
訾振军 |
增持 |
56875524 |
5687.55万股 |
0.14% |
好仓 |
2020-11-27 |
| 启明医疗-B |
訾振军 |
减持 |
-56875524 |
0.12万股 |
0.00% |
好仓 |
2020-11-27 |
| 启明医疗-B |
梁颕宇 |
增持 |
37185479 |
6752.80万股 |
0.16% |
好仓 |
2020-11-27 |
| 启明医疗-B |
梁颕宇 |
减持 |
-37185479 |
0.00万股 |
0.00% |
好仓 |
2020-11-27 |
| 康龙化成 |
JPMorgan Chase & Co. |
增持 |
2142385 |
1908.39万股 |
0.14% |
好仓 |
2020-11-27 |
| 泰格医药 |
JPMorgan Chase & Co. |
增持 |
3308197 |
1887.61万股 |
0.15% |
好仓 |
2020-11-27 |
| 启明医疗-B |
Qiming Venture Partners III, L.P. |
减持 |
-16788728 |
0.00万股 |
0.00% |
好仓 |
2020-11-27 |
| 启明医疗-B |
Qiming GP III, L.P. |
减持 |
-37185479 |
0.00万股 |
0.00% |
好仓 |
2020-11-27 |
| 启明医疗-B |
Qiming Corporate GP III, Ltd. |
减持 |
-37185479 |
0.00万股 |
0.00% |
好仓 |
2020-11-27 |
| 启明医疗-B |
Ming Zhi Investments Limited |
增持 |
16788728 |
4713.12万股 |
0.11% |
好仓 |
2020-11-27 |
| 启明医疗-B |
Qiming GP III, L.P. |
增持 |
37185479 |
6752.80万股 |
0.16% |
好仓 |
2020-11-27 |
| 启明医疗-B |
Qiming Corporate GP III, Ltd. |
增持 |
37185479 |
6752.80万股 |
0.16% |
好仓 |
2020-11-27 |
| 启明医疗-B |
Horizon Binjiang LLC |
减持 |
-38651618 |
930.28万股 |
1.00% |
好仓 |
2020-11-27 |
| 启明医疗-B |
Horizon Binjiang LLC |
增持 |
38651618 |
3865.16万股 |
0.09% |
好仓 |
2020-11-27 |
| 启明医疗-B |
RieschelGary Edward |
减持 |
-37185479 |
0.00万股 |
0.00% |
好仓 |
2020-11-27 |
| 启明医疗-B |
RieschelGary Edward |
增持 |
37185479 |
6752.80万股 |
0.16% |
好仓 |
2020-11-27 |
| 启明医疗-B |
邝子平 |
增持 |
37185479 |
6752.80万股 |
0.16% |
好仓 |
2020-11-27 |
| ESR |
Warburg Pincus Partners, L.P. |
减持 |
-182000000 |
9925.31万股 |
0.03% |
好仓 |
2020-11-27 |
